Research progress on therapeutic strategies for improving pulmonary vascular remodeling in pulmonary hypertension
- Author:
Xiang-Yun GAI
1
;
En-Qi ZHAO
1
;
Yan-Feng HE
1
;
Yue-Fu ZHAO
1
;
Jin-Yu WANG
1
;
Feng-Run LI
1
;
Xiang-Yun GAI
2
;
En-Qi ZHAO
2
;
Yan-Feng HE
2
;
Yue-Fu ZHAO
2
;
Jin-Yu WANG
2
;
Feng-Run LI
2
;
Zhan-Qiang LI
3
Author Information
- Publication Type:Journal Article
- Keywords: chemical drugs; monomer of traditional Chinese medicine; pulmonary artery smooth muscle cell proliferation; pulmonary hypertension; pulmonary vascular remodeling; target; traditional Chinese medicine preparation and compound
- From: Chinese Pharmacological Bulletin 2022;38(11):1612-1616
- CountryChina
- Language:Chinese
- Abstract: Pulmonary hypertension(PH)is a chronic,progressive,high-mortality disease characterized by a continuous increase in pulmonary vascular pressure. All types of PH have the same characteristics,i.e.,the excessive proliferation,anti-apoptosis and inflammation of pulmonary artery endothelial cells and smooth muscle cells,which leads to progressive thickening of pulmonary small vessels,resulting in pulmonary vascular remodeling and increased pulmonary vascular resistance,ultimately leading to right ventricular hypertrophy,heart failure,and death. The drugs used to treat PH mainly include L-type calcium channel blockers,phosphodiesterase 5 inhibitors,guanosine cyclase activators,endothelin receptor antagonists,and synthetic prostacyclin and its analogues. These drugs reduce pulmonary artery pressure by relaxing pulmonary blood vessels but do not cure the patient,and their prognosis remains poor. Therefore,the development of drugs that can effectively improve or even reverse pulmonary vascular remodeling is the key to treating PH. In recent years,studies on pulmonary vascular remodeling mainly included(1)the synthesis of new small-molecule compounds;(2)the transformation of mature drugs,such as the use of drug combinations and dosage form transformation,etc.;(3)the pharmacodynamic evaluation of traditional Chinese medicines and derived compounds based on the theory of "lung distension";(4)research into monomers of traditional Chinese medicine; and(5)research into new targets.
